Advertisement
Singapore markets closed

  • Straits Times Index

    3,404.47
    -6.34 (-0.19%)
     

  • S&P 500

    5,572.02
    +4.83 (+0.09%)
     

  • Dow

    39,541.14
    +165.27 (+0.42%)
     

  • Nasdaq

    18,358.79
    +6.03 (+0.03%)
     

  • Bitcoin USD

    56,312.37
    -403.34 (-0.71%)
     

  • CMC Crypto 200

    1,186.16
    +20.05 (+1.71%)
     

  • FTSE 100

    8,208.50
    +4.57 (+0.06%)
     

  • Gold

    2,384.60
    -13.10 (-0.55%)
     

  • Crude Oil

    82.65
    -0.51 (-0.61%)
     

  • 10-Yr Bond

    4.2840
    +0.0120 (+0.28%)
     

  • Nikkei

    40,780.70
    -131.67 (-0.32%)
     

  • Hang Seng

    17,524.06
    -275.55 (-1.55%)
     

  • FTSE Bursa Malaysia

    1,611.02
    -5.73 (-0.35%)
     

  • Jakarta Composite Index

    7,250.98
    -2.40 (-0.03%)
     

  • PSE Index

    6,529.43
    +36.68 (+0.56%)
     

Affimed N.V.: Q1 Earnings Snapshot

Associated Press Finance
·1-min read

MANNHEIM, Germany (AP) — MANNHEIM, Germany (AP) — Affimed N.V. (AFMD) on Wednesday reported a loss of $20.8 million in its first quarter.

On a per-share basis, the Mannheim, Germany-based company said it had a loss of $1.38.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.73 per share.

The drug developer posted revenue of $168,300 in the period. Its adjusted revenue was $168,000.

Affimed N.V. shares have increased 4.5% since the beginning of the year. The stock has decreased 11% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AFMD at https://www.zacks.com/ap/AFMD